- Home
- CVAC
CVAC
CureVac N.V.
as 05-30-2025 4:00pm EST
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
| Founded: | 2000 | Country: | Germany |
| Employees: | N/A | City: | N/A |
| Market Cap: | 764.4M | IPO Year: | 2020 |
| Target Price: | $14.00 | AVG Volume (30 days): | 779.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.87 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.37 - $5.28 | Next Earning Date: | 05-20-2025 |
| Revenue: | $566,039,775 | Revenue Growth: | 787.60% |
| Revenue Growth (this year): | -86.91% | Revenue Growth (next year): | 37.79% |
Latest CureVac N.V. News
CVAC Breaking Stock News: Dive into CVAC Ticker-Specific Updates for Smart Investing
Simply Wall St.
4 days ago
We Think CureVac's (NASDAQ:CVAC) Robust Earnings Are Conservative
Simply Wall St.
5 days ago
CureVac First Quarter 2025 Earnings: Misses Expectations
Simply Wall St.
8 days ago
Earnings Beat: CureVac N.V. (NASDAQ:CVAC) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
ACCESS Newswire
11 days ago
CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates
Simply Wall St.
18 days ago
May 2025's Promising Penny Stocks To Consider
MT Newswires
a month ago
UBS Trims Price Target on CureVac to $12 From $13, Maintains Buy Rating
Simply Wall St.
2 months ago
CureVac Among 3 Promising Penny Stocks To Watch
TipRanks
2 months ago
Prada to acquire Versace, CarMax reports mixed Q4 results: Morning Buzz
Compare CVAC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CVAC CureVac N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.